Font Size: a A A
Keyword [Percutaneous Transluminal Angioplasty]
Result: 41 - 60 | Page: 3 of 6
41. Genetic Polymorphisms And Antiplatelet Effects Of Clopidogrel In Patients With Percutaneous Transluminal Angioplasty And Stenting
42. Study On Application Of Catheter-directed Thrombolysis In Chronic Limb Ischemia Disease
43. Construction Of Artery Injury Model And Transplantation Of Endothelial Progenitor Cells To Prevent Restenosis After Percutaneous Transluminal Angioplasty
44. Evaluation Of The Quality Of Life In Patients With Below-knee Arterial Occlusive Disease After Interventional Therapy
45. The Effect Evalation Of Compound Danshen Dripping Pill In LDASO Patients After Lower-Limb Endovascular Interventions
46. Combined Thromboaspiration Via Sheath And Percutaneous Transluminal Angioplasty For Occluded Hemodialysis Grafts:A Report Of 22 Cases Observed In A Single Center
47. The Clinical Features Of Transplant Renal Artery Stenosis And Related Interventional Therapy
48. The Characteristics Analysis Of Budd-chiari Syndrome In Henan Province And Its Therapeutic Effect After Interventional Therapy
49. Effect Of Atorvastatin On Restenosis Post-PTA In Diabetic Lower Extremity Peripheral Arterial Disease
50. The Endovascular Treatment For TASC Ⅱ C And D Femoropopliteal Lesions:The Clinical Efficiency And Safety
51. Clinical Characteristics,Treatment And Prognosis Of Renal Artery Fibromuscular Dysplasia
52. Clinical Curative Effects Of PTAS For Symptomatic Severe MCA Stenosis
53. The Comparative Study Of PTAS And Medical Management On Symptomatic Intracranial Atherosclerotic Stenosis
54. Clinical Significance Of Transcutaneous Oxygen Pressure Measurement In Evaluating The Efficacy Of Percutaneous Transluminal Angioplasty In Patients With Lower Arteriosclerosis Obliteran
55. Interventional Therapy’s Curative Effect In The Treatment Of Iliac Vein Compression Syndrome
56. The Efficacy And Safety Of The Drug-Eluting Balloons Used In Treating Femoral-Popliteal Arteriosclerosis Obliteration
57. Analysis Of Patency Rate And Influencing Factors After Percutaneous Transluminal Angioplasty
58. Experimental Study Of The Tetramethylpyrazine-coated Balloon In The Post-percutaneous Transluminal Angioplasty Restenosis Model
59. Comparative Study Of Sarpogrelate Hydrochloride And Cilostazol In Patients With Lower Limb Arteriosclerosis Obliterans After Percutaneous Transluminal Angioplasty
60. Therapeutic Effects Between The Percutaneous Transluminal Angioplasty And Stent And Medical Treatment On Patients With Symptomatic Intracranial Vertebral Artery Atherosclerotic Stenosis And Non-disabling Ischemic Cerebrovascular Events
  <<First  <Prev  Next>  Last>>  Jump to